Menopausal Women clinical trials

Explore recruiting menopausal women clinical trials.

Recruiting menopausal women studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Menopausal Women trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase I study to evaluate the Pharmacokinetics and Safety of Letrozole LEBE in Healthy Post-menopausal Women.

Czechia, Bulgaria

Human Pharmacology (Phase I)- Other EU CTIS Study details

Randomized double blind phase 2 trial of baby exemestane versus baby tamoxifen in post-menopausal women at high risk for breast cancer. BabyTEARS (Baby Tamoxifen or Exemestane Assessment Randomized Study)

Italy, Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

The AGAINST-PLD; An investigator-driven, randomized, open label clinical trial assessing efficacy of leuprorelin to halt disease progression in PLD

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

SIE-1

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase II clinical trial targeting estrogen receptor negative or PAM50 non-luminal disease with Atezolizumab in combination with Trastuzumab and Vinorelbine in HER2-positive advanced/metastatic breast cancer – ATREZZO Study

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

PROPOSE: Effect of Intravaginal Prasterone on Genitourinary Syndrome in Women in Menopause with previous Breast Cancer or currently under treatment with endocrine therapy for Breast Cancer with aromatase inhibitor +/- LHRHa

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Menopausal Women trials by city

Menopausal Women in Toronto Menopausal Women in Vancouver Menopausal Women in Montreal Menopausal Women in Calgary Menopausal Women in Edmonton Menopausal Women in Ottawa Menopausal Women in Winnipeg Menopausal Women in Quebec City Menopausal Women in Hamilton Menopausal Women in Kitchener Menopausal Women in London Menopausal Women in Halifax Menopausal Women in New York Menopausal Women in Los Angeles Menopausal Women in Chicago Menopausal Women in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease